C2HF5 17,9480 %;C3H2F4 19,3479 %;C2H2F4 21,9674 %;CH2F2 40,7367 %
Issue Date:
Last revised date:
In vivo
Component information
2,3,3,3-Tetrafluoropropene
Carcinogenicity
Product
Reproductive toxicity
Product
Reproductive toxicity ( Fertility)
Component information
2,3,3,3-Tetrafluoropropene
Developmental toxicity ( Teratogenicity)
Component information
2,3,3,3-Tetrafluoropropene
Specific Target Organ Toxicity - Single Exposure
Product
Specific Target Organ Toxicity - Repeated Exposure
Product
Aspiration Hazard
Product
Other Relevant Toxicity Information
Difluoromethane
SDS_ GB - 000010022608
SAFETY DATA SHEET
13.11.2014
22.07.2015
Chromosome aberration ( OECD Guideline 474 (Mammalian Erythrocyte
Micronucleus Test)): Negative.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Rat NOAEL - No Observable Adverse Effect Level: 50,000 ppm
Rat Inhalation ( OECD Guideline 414 (Prenatal Developmental Toxicity Study))
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Not applicable to gases and gas mixtures..
Cardiac sensitisation threshold limit
>350000 ppm
Beagle (dog) LOAEC
Cardiac sensitisation threshold limit
350000 ppm
Beagle (dog) NOAEC
Light hydrocarbons like this one have been associated with cardiac sensitisation in
abuse situations. Hypoxia or the injection of adrenaline-like substances enhances
these effects.
Version: 2. 0
SDS No.: 000010022608
10/16